Adicet Bio, Inc. Operating Income Loss

• Adicet Bio, Inc. showed an increase of +4.3% in Operating Income Loss from 2024 to 2025.
• This data is from Adicet Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Adicet Bio, Inc.'s Operating Income Loss has declined by 546.7%.
• Historical annual values: Fiscal year 2025: -$122.11 million | Fiscal year 2024: -$127.62 million | Fiscal year 2023: -$152.04 million | Fiscal year 2022: -$72.55 million | Fiscal year 2021: -$61.43 million | Fiscal year 2020: -$39.19 million | Fiscal year 2019: -$31.39 million | Fiscal year 2018: -$14.96 million | Fiscal year 2017: -$18.88 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026